Prime Medicine (PRME) Operating Expenses: 2021-2025
Historic Operating Expenses for Prime Medicine (PRME) over the last 4 years, with Sep 2025 value amounting to $55.2 million.
- Prime Medicine's Operating Expenses rose 1.39% to $55.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $209.9 million, marking a year-over-year decrease of 7.55%. This contributed to the annual value of $205.4 million for FY2024, which is 0.32% up from last year.
- Latest data reveals that Prime Medicine reported Operating Expenses of $55.2 million as of Q3 2025, which was up 1.30% from $54.5 million recorded in Q2 2025.
- In the past 5 years, Prime Medicine's Operating Expenses ranged from a high of $68.0 million in Q4 2023 and a low of $10.4 million during Q3 2021.
- Moreover, its 3-year median value for Operating Expenses was $53.8 million (2025), whereas its average is $52.2 million.
- Data for Prime Medicine's Operating Expenses shows a peak YoY increase of 203.59% (in 2022) and a maximum YoY decrease of 35.60% (in 2022) over the last 5 years.
- Prime Medicine's Operating Expenses (Quarterly) stood at $60.1 million in 2021, then crashed by 35.60% to $38.7 million in 2022, then surged by 75.89% to $68.0 million in 2023, then tumbled by 31.80% to $46.4 million in 2024, then grew by 1.39% to $55.2 million in 2025.
- Its last three reported values are $55.2 million in Q3 2025, $54.5 million for Q2 2025, and $53.8 million during Q1 2025.